Your risk of eye complications is low if you do not have diabetes
I believe that NLRP3 , NR3C1, Amylin, Apelin, Activin and many other targets we described in our prior publications are poised to complement the effects of GLP-1, creating comprehensive anti-aging regimens
Obesity is a chronic condition that has become an epidemic worldwide and can lead to serious health problems such as diabetes, heart disease, and stroke
whether it requires special preservatives, stabilizers etc.)
To study whether GLP-1R activation in TNC microglia can alleviate NTG-induced allodynia, the selective GLP-1R agonist liraglutide (800 g/kg, n = 8 per group) and the antagonist exendin(939) (50 g/kg, n = 8 per group) were i.p